Entering the era of designer babies

Modifying DNA

Technology goes far beyond simply merging technology with biology; in some cases, the goal is to directly alter our biological code—modifying the genetic code of a human embryo not to cure a fatal hereditary disease, but to demonstrate that science has learned to rewrite DNA without causing irreversible damage.

The most dangerous debate in modern bioethics has just been reignited.

In June 2026, scientists at Columbia University conducted experiments using an advanced base-editing technique on human zygotes, reviving an old fear: the possibility that humanity is definitively entering the era of designer babies.

Gene editing in human embryos has been overshadowed since 2018, the year Chinese scientist He Jiankui shocked the scientific community by announcing the birth of history's first genetically modified baby girls. Using the CRISPR tool, he altered genes linked to HIV resistance, sparking a global outcry and facing accusations of crossing a line for which humanity was not yet prepared.

The main problem with that technique was the need to cut both strands of the DNA—a powerful yet potentially dangerous process capable of causing unwanted mutations and permanent genome damage. It was precisely to overcome these limitations that the team led by geneticist Jetter Eggley opted for a different approach: so-called base editing. Instead of breaking both strands of the molecule, the technique alters only one, changing individual letters of the genetic code with extremely high precision.

To validate the tool, researchers selected genes related to cholesterol metabolism and hemoglobin production; the goal was not to develop a medical therapy but to test the technology's capabilities in human embryos using genomic regions well-understood by science. However, the results revealed a reality more complex than anticipated. Many embryos exhibited the so-called mosaic effect: instead of all cells carrying the same genetic modification, different parts of the embryo ended up with distinct genetic codes.

In practical terms, this is akin to constructing an organism composed of different cell populations, creating unpredictable biological consequences. Bioethicists like Ena Iris from Wake Forest University warn that if such embryos were implanted and carried to term, serious health issues could arise—problems that might not manifest until years later. The controversy was further fueled by the study's funding; some of the resources came from Nucle Genomics, a private company linked to the market for genetic analysis in in vitro fertilization.

This reignited fears that genetic engineering might cease to be an exclusively medical tool and instead become a commercial service aimed at selecting and enhancing human traits. It is precisely at this point that the scientific community's greatest concern arises; pioneering researchers like Alexis Conor argue that this type of experiment breaks a long-standing, informal pact among geneticists.

The most scathing criticism came from Deor Ernof of the University of California, Berkeley, who stated that work like this could serve as a veritable manual for future enhancement programs. If the technology becomes safe and efficient, the line separating the curing of diseases from the selection of physical traits, intelligence, or cognitive performance could vanish.